evolcSign in

Evidensa

HTA, pharmacoeconomic and market access consulting for healthcare technology companies entering Slovakia's reimbursement system

Zvolen, SlovakiaFounded 2023evidensa.sk

Highlights

  • Young companyFounded 2023
  • ProfitableFY2025 net profit €150k · RÚZ
  • GrowingRevenue +42% YoY (FY2025) · RÚZ
  • New on EvolcAdded 2026-10-17

About Evidensa

Evidensa provides consulting on market access and health technology assessment (HTA) for medicines and other healthcare technologies seeking inclusion in Slovakia's reimbursement system. Services include pharmacoeconomic analyses, reimbursement application support, evidence synthesis and training.

Its customers are organizations seeking reimbursement for healthcare technologies, though the website does not specify customer types. The company is registered in Zvolen, Slovakia, and was founded in 2023. It lists a Junior Project Manager (HTA) opening.

Product: Market access and HTA consulting, pharmacoeconomic analyses, reimbursement application support, evidence reviews and training.

Financials

FY2025FY2024FY202310 months
Revenue€449k€316k€128k
Growth+42%——
EBITDA€210k€114k€53k
Operating profit€192k€112k€52k
Net profit€150k€86k€41k
Net margin33.3%27.2%32.1%
Personnel costs€157k€111k€32k
Total assets€280k€206k€91k
Cash€16k€14k€32k
Liabilities€125k€84k€45k
Equity€155k€122k€46k

As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.

Open jobs

No open positions listed right now.

Leadership

Tech stack

  • Bootstrap
  • Cloudflare
  • Google Tag Manager
  • Google reCAPTCHA
  • jQuery